We’re always about innovation, research and challenging the impossible.

Our goal is to advance in the field of cannabinoid-based cancer therapies continuously, until the „impossible“ or “incurable” is no longer associated with cancer treatment.

We research and develop synthetic cannabinoids based on molecular mechanisms of diseases and cannabinoid treatment sensitivity markers used in personalized oncological diagnostics.

Read more ⟶

Our partners

Lithuanian National Cancer Institute

nvi logo copy 2

Established in 1931, the National Cancer Institute (NVI) is the only specialised oncology institution in Lithuania operating as the clinical cancer centre certified and accredited by the Organisation of European Cancer Institutes.

NVI is involved in diverse research studies related to nano-technologies, molecular biology, genetics and the most advanced immunotherapy conducted at both the national and the international levels.

The institute is developing foundations for individualised precision medicine and this approach includes early and accurate cancer diagnosis, selection of the most appropriate treatment strategies, active prevention and monitoring programs and palliative medicine.


We believe that scientific research is essential. Our research & development team consists of experienced researchers, chemists and biochemists, but the quality that we value most is their forward-thinking approach towards all our research projects.

View team